Articles

Explore our articles to learn more about our programs, our people, and the communities we work with.

All articles
Related articles

Read our latest

1049 Result s
  1. President and CEO Steve Davis on PATH programs in Uganda and the need for high-quality cancer screening and care.
  2. We call it a transmission-blocking vaccine (TBV) and it could break the never-ending cycle of malaria. How's it work?
  3. The global supply of an essential malaria drug made with semisynthetic artemisinin is now less dependent on crop yields, a breakthrough 10 years in the making.
  4. Our new Innovation Hubs will help local entrepreneurs, academics, manufacturers, and governments put emerging health technologies into the hands of communities who need them.